Canada Life’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,200
Closed -$121K 2250
2023
Q2
$121K Sell
6,200
-6,116
-50% -$119K ﹤0.01% 1899
2023
Q1
$349K Buy
12,316
+1,151
+10% +$32.6K ﹤0.01% 1785
2022
Q4
$326K Hold
11,165
﹤0.01% 1804
2022
Q3
$295K Buy
11,165
+128
+1% +$3.38K ﹤0.01% 1781
2022
Q2
$490K Buy
11,037
+857
+8% +$38K ﹤0.01% 1676
2022
Q1
$517K Buy
10,180
+686
+7% +$34.8K ﹤0.01% 1703
2021
Q4
$484K Sell
9,494
-147
-2% -$7.49K ﹤0.01% 1712
2021
Q3
$541K Hold
9,641
﹤0.01% 1715
2021
Q2
$412K Hold
9,641
﹤0.01% 1781
2021
Q1
$402K Sell
9,641
-1,909
-17% -$79.6K ﹤0.01% 1795
2020
Q4
$538K Sell
11,550
-650
-5% -$30.3K ﹤0.01% 1729
2020
Q3
$518K Sell
12,200
-461
-4% -$19.6K ﹤0.01% 1664
2020
Q2
$608K Sell
12,661
-1,014
-7% -$48.7K ﹤0.01% 1634
2020
Q1
$629K Buy
13,675
+1,017
+8% +$46.8K ﹤0.01% 1515
2019
Q4
$754K Buy
+12,658
New +$754K ﹤0.01% 1600
2019
Q3
Sell
-14,493
Closed -$806K 2378
2019
Q2
$806K Sell
14,493
-716
-5% -$39.8K ﹤0.01% 1630
2019
Q1
$767K Buy
15,209
+1,261
+9% +$63.6K ﹤0.01% 1492
2018
Q4
$518K Hold
13,948
﹤0.01% 1664
2018
Q3
$967K Buy
13,948
+3,300
+31% +$229K ﹤0.01% 1538
2018
Q2
$806K Hold
10,648
﹤0.01% 1611
2018
Q1
$561K Sell
10,648
-898
-8% -$47.3K ﹤0.01% 1703
2017
Q4
$617K Hold
11,546
﹤0.01% 1670
2017
Q3
$678K Hold
11,546
﹤0.01% 1646
2017
Q2
$910K Buy
11,546
+302
+3% +$23.8K ﹤0.01% 1552
2017
Q1
$932K Buy
11,244
+981
+10% +$81.3K ﹤0.01% 1534
2016
Q4
$814K Sell
10,263
-530
-5% -$42K ﹤0.01% 1557
2016
Q3
$755K Buy
10,793
+9,861
+1,058% +$690K ﹤0.01% 1544
2016
Q2
$36K Hold
932
﹤0.01% 2385
2016
Q1
$38K Hold
932
﹤0.01% 2218
2015
Q4
$83K Hold
932
﹤0.01% 1891
2015
Q3
$69K Buy
+932
New +$69K ﹤0.01% 1941